Biotech Hangout Profile picture
Weekly discussion of biotech news, FDA, deals, & data w/ @daphnezohar @jschimmer_e @timopler @LifeSciVC, @cngarabedian & a community of biotech insiders
Jan 12 16 tweets 3 min read
On today’s #BiotechHangout @daphnezohar @biotech1 @bradloncar @SamFazeli8 & @TheDawnBell discuss #JPM24 takeaways, deals: $MRK/ $HARP, $JNJ/ $AMAM, $GSK/ Aiolos, $BSX/ $AXNX + $NVS deal spree ( $CYTK, Calypso Biotech, Shanghai Argo, $LLY/Isomorphic), plus Metagenomi & ArriVent preclinical IPOs, $KYMR offering, $ALPMY CRL, $VRTX pauses trial & more twitter.com/i/spaces/1ZkKz…Image @daphnezohar @biotech1 @bradloncar @SamFazeli8 @TheDawnBell @MatteisPaul @TimOpler @LifeSciVC @mpreminger @JMaraganore @Seals310 The hosts start off this week’s #BiotechHangout with takeaways from #JPM24. @daphnezohar notes “for the first time in 3 years it felt really positive” adding there were lots of M&A deals.
Feb 17, 2023 21 tweets 15 min read
twitter.com/i/spaces/1PlJQ… .@daphnezohar notes that pharma heads of R&D are leaving after ~5 years with @jaybradner, @mmammen, John Reed, Hal Barron, Rupert Vessey being recent examples. Asks @andy_plump (8 yrs @TakedaPharma) what a minimum tenure is to make an impact #BiotechHangout